Cerebral Perfusion Changes after Acetyl-L-Carnitine Treatment in Early Alzheimer’s Disease Using Single Photon Emission Computed Tomography

키워드

참고문헌 (37)

1. Helmes E, "Beyond memory impairment: cognitive changes in Alzheimer’s disease", Arch Clin Neuropsychol, 17, pp.179~193 (2002)
2. Burlina AP, "Uptake of acetyl-L-carnitine in the brain", Neurochem Res, 14, pp.489~493 (1989)
3. Pettegrew JW, "Acetyl-L-carnitine physicalchemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer’s disease and geriatric depression", Mol Psychiatry, 5, pp.616~632 (2000)
4. Montgomery SA, "Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer’s disease", Int Clin Psychopharmacol, 18, pp.61~71 (2003)
5. Spagnoli A, "Long-term acetyl-L-carnitine treatment in Alzheimer’s disease", Neurology, 41, pp.1726~1732 (1991)
6. Pettegrew JW, "Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer’s disease", Neurobiol Aging, 16, pp.1~4 (1995)
7. Henderson TA, "The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging", CNS Spectr, pp.176~206 (2012)
8. -IBVM in early Alzheimer’s disease, "Neuroimage", 2008, 280~288
9. Kendziorra K, "Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography", Eur J Nucl Med Mol Imaging, 38, pp.515~525 (2011)
10. Minoshima S, "Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease", Ann Neurol, 42, pp.85~94 (1997)
11. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" (1994), American Psychiatric Association
12. McKhann G, "Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
13. Morris JC, "The consortium to Establish a Registry for Alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease", Neurology, 39, pp.1159~1165 (1989)
14. 최성혜, "한국판 Global Deterioration Scale의 타당도", 대한신경과학회지, 20(6), pp.612~617 (2002), 대한신경과학회
15. Kang Y, "A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients", J Korean Neurol Assoc, 15, pp.300~308 (1997)
16. Choi SH, "The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients", J Korean Med Sci, 15, pp.609~615 (2000)
17. Tzourio-Mazoyer N, "Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain", Neuroimage, 15, pp.273~289 (2002)
18. Pickut BA, "Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type", Psychiatry Res, 90, pp.103~112 (1999)
19. Soonawala D, "Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer’s disease: normalizing to cerebellar tracer uptake", Neuroimage, 17, pp.1193~1202 (2002)
20. Burns A, "Progression of cognitive impairment in Alzheimer’s disease", J Am Geriatr Soc, 39, pp.39~45 (1991)
21. Benoit M, "One-year longitudinal evaluation of neuropsychiatric symptoms in Alzheimer’s disease. The REAL.FR study", J Nutr Health Aging, 9, pp.95~99 (2005)
22. Baron JC, "In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer’s disease", Neuroimage, 14, pp.298~309 (2001)
23. Frisoni GB, "Detection of grey matter loss in mild Alzheimer’s disease with voxel based morphometry", J Neurol Neurosurg Psychiatry, 73, pp.657~664 (2002)
24. Johnson NA, "Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR Imaging: initial experience", Radiology, 234, pp.851~859 (2005)
25. Mountjoy CQ, "Cortical neuronal counts in normal elderly controls and demented patients", Neurobiol Aging, 4, pp.1~11 (1983)
26. Royall DR, "Insular Alzheimer disease pathology and the psychometric correlates of mortality", Cleve Clin J Med, 75(Suppl 2), pp.S97~S99 (2008)
27. Scheff SW, "Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer’s disease", J Alzheimers Dis, 24, pp.547~557 (2011)
28. Cavanna AE, "The precuneus: a review of its functional anatomy and behavioural correlates", Brain, 129(Pt 3), pp.564~583 (2006)
29. Fransson P, "The precuneus", posterior cingulate cortex plays a pivotal role in the default mode network: evidence from a partial correlation network analysis, 2008, pp.42, 1178~1184
30. Rombouts SA, "Altered resting state networks in mild cognitive impairment and mild Alzheimer’s disease: an fMRI study", Hum Brain Mapp, 26, pp.231~239 (2005)
31. Bradley KM, "Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer’s disease", Brain, 125(Pt 8), pp.1772~1781 (2002)
32. Sakamoto S, "Apolipoprotein E genotype and early Alzheimer’s disease: a longitudinal SPECT study", J Neuroimaging, 13, pp.113~123 (2003)
33. Salmon E, "Voxelbased analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer’s disease", Hum Brain Mapp, 10, pp.39~48 (2000)
34. 류선영, "Measurement of Precuneal and Hippocampal Volumes Using Magnetic Resonance Volumetry in Alzheimer’s Disease", Journal of Clinical Neurology, 6(4), pp.196~203 (2010), 대한신경과학회
35. Sperling RA, "Amyloid deposition is associated with impaired default network function in older persons without dementia", Neuron, 63, pp.178~188 (2009)
36. Petrella JR, "Default mode network connectivity in stable vs progressive mild cognitive impairment", Neurology, 76, pp.511~517 (2011)
37. Yun K, "Changes in cerebral glucose metabolism after 3 weeks of noninvasive electrical stimulation of mild cognitive impairment patients", Alzheimers Res Ther, 8, pp.49~ (2016)

관련 논문AI추천